Comparison between Chemplast Sanmar IPO and Windlas Biotech IPO.
Chemplast Sanmar IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Chemplast Sanmar IPO is up to ₹3,850.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Chemplast Sanmar IPO is ₹541.00 per share and of Windlas Biotech IPO is ₹460.00 per share.
| Chemplast Sanmar IPO | Windlas Biotech IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹5 per share |
| Issue Price (Lower) | ₹530.00 per share | ₹448.00 per share |
| Issue Price (Upper) | ₹541.00 per share | ₹460.00 per share |
| Issue Price (Final) | ₹541.00 per share | ₹460.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 27 shares | 30 shares |
| Fresh Issue Size | 2,40,29,574 shares | 35,86,956 shares |
| Fresh Issue Size (Amount) | up to ₹1,300.00 Cr | up to ₹165.00 Cr |
| OFS Issue Size | 4,71,34,935 shares | 51,42,067 shares |
| OFS Issue Size (Amount) | up to ₹2,550.00 Cr | up to ₹236.54 Cr |
| Issue Size Total | 7,11,64,509 shares | 87,29,023 shares |
| Issue Size Total (Amount) | up to ₹3,850.00 Cr | up to ₹401.54 Cr |
Chemplast Sanmar IPO opens on Aug 10, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Chemplast Sanmar IPO and Windlas Biotech IPO is Aug 12, 2021, and Aug 06, 2021, respectively.
| Chemplast Sanmar IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Aug 09, 2021 | Aug 03, 2021 |
| Issue Open | Aug 10, 2021 | Aug 04, 2021 |
| Issue Close | Aug 12, 2021 | Aug 06, 2021 |
| Basis Of Allotment (Tentative) | Aug 18, 2021 | Aug 11, 2021 |
| Initiation of Refunds (Tentative) | Aug 20, 2021 | Aug 12, 2021 |
| Credit of Share (Tentative) | Aug 23, 2021 | Aug 13, 2021 |
| Listing date (Tentative) | Aug 24, 2021 | Aug 16, 2021 |
| Anchor Lockin End date 1 | Sep 17, 2021 | Sep 10, 2021 |
| Anchor Lockin End date 2 | Nov 16, 2021 | Nov 09, 2021 |
Chemplast Sanmar IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .
| Chemplast Sanmar IPO | Windlas Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 78 | ||||
| Promoter Shareholding (Post-Issue) | 54.99 | 65.16 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹8553.73 Cr. | ₹1002.54 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Chemplast Sanmar IPO Retail Individual Investors (RII) are offered 71,16,450 shares while in Windlas Biotech IPO retail investors are offered 71,16,450 shares. Qualified Institutional Buyers (QIB) are offered 2,13,49,354 shares in Chemplast Sanmar IPO and 17,45,804 shares in Windlas Biotech IPO.
| Chemplast Sanmar IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 3,20,24,029 shares | 26,18,706 shares |
| Market Maker Reservation | ||
| QIB | 2,13,49,354 shares | 17,45,804 shares |
| NII | 1,06,74,676 shares | 13,09,354 shares |
| RII | 71,16,450 shares | 30,55,159 shares |
| Employee | ||
| Others | ||
| Total | 7,11,64,509 shares | 87,29,023 shares |
Chemplast Sanmar IPO subscribed 2.17x in total, whereas Windlas Biotech IPO subscribed 22.44x.
| Chemplast Sanmar IPO | Windlas Biotech IPO | |
|---|---|---|
| QIB (times) | 2.70x | 24.40x |
| NII (times) | 1.03x | 15.73x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.29x | 24.22x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.17x | 22.44x |
